Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Kenneth Galbraith 5th highest paid CEO in CANADA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by stockbuphoonon Jun 08, 2020 2:55pm
88 Views
Post# 31125410

RE:RE:Kenneth Galbraith 5th highest paid CEO in CANADA

RE:RE:Kenneth Galbraith 5th highest paid CEO in CANADA

This is absolutely shocking for someone who produced nothing, leads an enterprise with market cap of only $250-300M and continues to kick the cab down the road on any clinical trials with 4050 after 5 years having passed on IPF and MetSyn. What is Thomvest thinking? They are paying them like they market cap of 10x like back in 2016.


Arrakis37 wrote:

LOL

Well deserved for a guy who have produced nothing.

What a joke 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities